Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Prothena Corp
PRTA
$467M
| $10.8M | 0.01% |
151,669
+63,725
| +72% | +$3.96M |
|
1927
Halozyme
HALO
$12.1B
| $10.8M | 0.01% |
265,273
+49,650
| +23% | +$2.08M |
|
1928
PUT
Stanley Black & Decker
SWK
$15B
| $10.8M | 0.01% |
+61,500
| New | +$12M |
|
1929
CALL
GE Aerospace
GE
$356B
| $10.8M | 0.01% |
2,941,975
+2,578,361
| +709% | +$166M |
|
1930
Lincoln National
LNC
$8.33B
| $10.8M | 0.01% |
156,465
+89,106
| +132% | +$5.82M |
|
1931
PUT
Equinix
EQIX
$106B
| $10.7M | 0.01% |
+13,600
| New | +$11.3M |
|
1932
Porch Group
PRCH
$1.98B
| $10.7M | 0.01% |
607,389
+395,019
| +186% | +$7.41M |
|
1933
ICU Medical
ICUI
$4.38B
| $10.7M | 0.01% |
45,959
-2,878
| -6% | -$604K |
|
1934
MacroGenics
MGNX
$260M
| $10.7M | 0.01% |
512,049
+29,720
| +6% | +$716K |
|
|
TWOA
1935
DELISTED
two
TWOA
| $10.7M | 0.01% |
1,094,572
-39,583
| -3% | -$387K |
|
1936
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.41B
| $10.7M | 0.01% |
240,872
+46,228
| +24% | +$2.15M |
|
1937
Sarepta Therapeutics
SRPT
$2.28B
| $10.7M | 0.01% |
115,652
+48,062
| +71% | +$3.7M |
|
|
SWET
1938
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
| $10.7M | 0.01% |
1,093,547
+16,755
| +2% | +$162K |
|
|
OPA
1939
DELISTED
Magnum Opus Acquisition Limited
OPA
| $10.7M | 0.01% |
1,079,872
+748,674
| +226% | +$7.3M |
|
1940
Par Pacific Holdings
PARR
$3.86B
| $10.7M | 0.01% |
679,291
+223,958
| +49% | +$3.47M |
|
|
VSTO
1941
DELISTED
Vista Outdoor Inc.
VSTO
| $10.7M | 0.01% |
264,803
+213,150
| +413% | +$8.78M |
|
1942
Quest Diagnostics
DGX
$27B
| $10.7M | 0.01% |
73,399
-158,043
| -68% | -$23.1M |
|
1943
Otter Tail
OTTR
$3.85B
| $10.7M | 0.01% |
190,507
+46,373
| +32% | +$2.46M |
|
1944
Nucor
NUE
$57.3B
| $10.7M | 0.01% |
108,240
-10,072
| -9% | -$1.07M |
|
1945
Stevanato
STVN
$6.09B
| $10.6M | 0.01% |
+420,434
| New | +$9.9M |
|
|
FRXB
1946
DELISTED
Forest Road Acquisition Corp. II
FRXB
| $10.6M | 0.01% |
1,090,359
+822,550
| +307% | +$8M |
|
1947
CALL
American Airlines Group
AAL
$9.08B
| $10.6M | 0.01% |
517,900
+300,000
| +138% | +$6.08M |
|
1948
PubMatic
PUBM
$745M
| $10.6M | 0.01% |
403,074
+312,471
| +345% | +$9.37M |
|
1949
Kinsale Capital Group
KNSL
$8.7B
| $10.6M | 0.01% |
65,674
-11,400
| -15% | -$1.98M |
|
|
MACQ
1950
DELISTED
MCAP Acquisition Corporation Class A Common Stock
MACQ
| $10.6M | 0.01% |
1,074,728
+767,507
| +250% | +$7.51M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.